The American Journal of Managed Care23h
Disease Activity, Safety Remain Following Switch From Infliximab Biosimilar to Originator in IBD
Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...
I Was Told It Was a Gluten Allergy, but I Was Diagnosed with Stage 4 Colon Cancer at Age 26 (Exclusive)
Shannin Desroches fought for a diagnosis after being dismissed. Now she tells PEOPLE that she's been given a 5% chance of ...